CorMedix
CRMD
C$16.03
Share price
-2.84%
Change (1 day)
147.27%
Change (1 year)
Categories
Revenue for CorMedix (CRMD)
Revenue in 2025 (TTM): C$0.11 Billion
According to CorMedix's latest financial reports the company's current revenue (TTM 
) is C$0.11 Billion. In 2024 the company made a revenue of C$62.38 Million an increase over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for CorMedix from 2009 to 2025
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2025 (TTM) | C$0.11 B | 88.56% |
| 2024 | C$62.38 M | |
| 2023 | N/A | -100% |
| 2022 | C$0.08 M | -63.53% |
| 2021 | C$0.24 M | -20.23% |
| 2020 | C$0.3 M | -17.55% |
| 2019 | C$0.36 M | -36.81% |
| 2018 | C$0.58 M | 41.4% |
| 2017 | C$0.41 M | 37.48% |
| 2016 | C$0.3 M | 3.32% |
| 2015 | C$0.29 M | 32.71% |
| 2014 | C$0.21 M | 10211.83% |
| 2013 | C$0 M | |
| 2012 | N/A | |
| 2011 | N/A | |
| 2010 | N/A | |
| 2009 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Becton Dickinson BDX | C$28.73 B | 25,176.84% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | C$1.28 B | 1,026.90% | 🇺🇸 USA |
 Utah Medical Products UTMD | C$54.07 M | -52.43% | 🇺🇸 USA |